Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.

A major obstacle to an effective myocardium stem cell therapy has always been the delivery and survival of implanted stem cells in the heart. Better engraftment can be achieved if cells are administered as cell aggregates, which maintain their extra-cellular matrix (ECM). We have generated spheroid...

Full description

Bibliographic Details
Main Authors: Francesca Oltolina, Andrea Zamperone, Donato Colangelo, Luca Gregoletto, Simone Reano, Stefano Pietronave, Simone Merlin, Maria Talmon, Eugenio Novelli, Marco Diena, Carmine Nicoletti, Antonio Musarò, Nicoletta Filigheddu, Antonia Follenzi, Maria Prat
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4572703?pdf=render
_version_ 1818265331006701568
author Francesca Oltolina
Andrea Zamperone
Donato Colangelo
Luca Gregoletto
Simone Reano
Stefano Pietronave
Simone Merlin
Maria Talmon
Eugenio Novelli
Marco Diena
Carmine Nicoletti
Antonio Musarò
Nicoletta Filigheddu
Antonia Follenzi
Maria Prat
author_facet Francesca Oltolina
Andrea Zamperone
Donato Colangelo
Luca Gregoletto
Simone Reano
Stefano Pietronave
Simone Merlin
Maria Talmon
Eugenio Novelli
Marco Diena
Carmine Nicoletti
Antonio Musarò
Nicoletta Filigheddu
Antonia Follenzi
Maria Prat
author_sort Francesca Oltolina
collection DOAJ
description A major obstacle to an effective myocardium stem cell therapy has always been the delivery and survival of implanted stem cells in the heart. Better engraftment can be achieved if cells are administered as cell aggregates, which maintain their extra-cellular matrix (ECM). We have generated spheroid aggregates in less than 24 h by seeding human cardiac progenitor cells (hCPCs) onto methylcellulose hydrogel-coated microwells. Cells within spheroids maintained the expression of stemness/mesenchymal and ECM markers, growth factors and their cognate receptors, cardiac commitment factors, and metalloproteases, as detected by immunofluorescence, q-RT-PCR and immunoarray, and expressed a higher, but regulated, telomerase activity. Compared to cells in monolayers, 3D spheroids secreted also bFGF and showed MMP2 activity. When spheroids were seeded on culture plates, the cells quickly migrated, displaying an increased wound healing ability with or without pharmacological modulation, and reached confluence at a higher rate than cells from conventional monolayers. When spheroids were injected in the heart wall of healthy mice, some cells migrated from the spheroids, engrafted, and remained detectable for at least 1 week after transplantation, while, when the same amount of cells was injected as suspension, no cells were detectable three days after injection. Cells from spheroids displayed the same engraftment capability when they were injected in cardiotoxin-injured myocardium. Our study shows that spherical in vivo ready-to-implant scaffold-less aggregates of hCPCs able to engraft also in the hostile environment of an injured myocardium can be produced with an economic, easy and fast protocol.
first_indexed 2024-12-12T19:49:06Z
format Article
id doaj.art-2224d588b376464e80bba0f141f76867
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T19:49:06Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-2224d588b376464e80bba0f141f768672022-12-22T00:14:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01109e013799910.1371/journal.pone.0137999Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.Francesca OltolinaAndrea ZamperoneDonato ColangeloLuca GregolettoSimone ReanoStefano PietronaveSimone MerlinMaria TalmonEugenio NovelliMarco DienaCarmine NicolettiAntonio MusaròNicoletta FilighedduAntonia FollenziMaria PratA major obstacle to an effective myocardium stem cell therapy has always been the delivery and survival of implanted stem cells in the heart. Better engraftment can be achieved if cells are administered as cell aggregates, which maintain their extra-cellular matrix (ECM). We have generated spheroid aggregates in less than 24 h by seeding human cardiac progenitor cells (hCPCs) onto methylcellulose hydrogel-coated microwells. Cells within spheroids maintained the expression of stemness/mesenchymal and ECM markers, growth factors and their cognate receptors, cardiac commitment factors, and metalloproteases, as detected by immunofluorescence, q-RT-PCR and immunoarray, and expressed a higher, but regulated, telomerase activity. Compared to cells in monolayers, 3D spheroids secreted also bFGF and showed MMP2 activity. When spheroids were seeded on culture plates, the cells quickly migrated, displaying an increased wound healing ability with or without pharmacological modulation, and reached confluence at a higher rate than cells from conventional monolayers. When spheroids were injected in the heart wall of healthy mice, some cells migrated from the spheroids, engrafted, and remained detectable for at least 1 week after transplantation, while, when the same amount of cells was injected as suspension, no cells were detectable three days after injection. Cells from spheroids displayed the same engraftment capability when they were injected in cardiotoxin-injured myocardium. Our study shows that spherical in vivo ready-to-implant scaffold-less aggregates of hCPCs able to engraft also in the hostile environment of an injured myocardium can be produced with an economic, easy and fast protocol.http://europepmc.org/articles/PMC4572703?pdf=render
spellingShingle Francesca Oltolina
Andrea Zamperone
Donato Colangelo
Luca Gregoletto
Simone Reano
Stefano Pietronave
Simone Merlin
Maria Talmon
Eugenio Novelli
Marco Diena
Carmine Nicoletti
Antonio Musarò
Nicoletta Filigheddu
Antonia Follenzi
Maria Prat
Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.
PLoS ONE
title Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.
title_full Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.
title_fullStr Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.
title_full_unstemmed Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.
title_short Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential.
title_sort human cardiac progenitor spheroids exhibit enhanced engraftment potential
url http://europepmc.org/articles/PMC4572703?pdf=render
work_keys_str_mv AT francescaoltolina humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT andreazamperone humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT donatocolangelo humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT lucagregoletto humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT simonereano humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT stefanopietronave humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT simonemerlin humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT mariatalmon humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT eugenionovelli humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT marcodiena humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT carminenicoletti humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT antoniomusaro humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT nicolettafiligheddu humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT antoniafollenzi humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential
AT mariaprat humancardiacprogenitorspheroidsexhibitenhancedengraftmentpotential